MX375182B - Comprimidos que tienen aceptacion mejorada y buena stabilidad durante el almacenamiento. - Google Patents

Comprimidos que tienen aceptacion mejorada y buena stabilidad durante el almacenamiento.

Info

Publication number
MX375182B
MX375182B MX2015007640A MX2015007640A MX375182B MX 375182 B MX375182 B MX 375182B MX 2015007640 A MX2015007640 A MX 2015007640A MX 2015007640 A MX2015007640 A MX 2015007640A MX 375182 B MX375182 B MX 375182B
Authority
MX
Mexico
Prior art keywords
tablets
storage stability
good storage
improved acceptance
acceptance
Prior art date
Application number
MX2015007640A
Other languages
English (en)
Other versions
MX2015007640A (es
Inventor
Patrick Billian
Hans-Jürgen Hamann
Venkata-Rangarao Kanikanti
Georg Schulte
Original Assignee
Elanco Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Animal Health Gmbh filed Critical Elanco Animal Health Gmbh
Publication of MX2015007640A publication Critical patent/MX2015007640A/es
Publication of MX375182B publication Critical patent/MX375182B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a comprimidos para animales que tienen una aceptación mejorada y buena estabilidad durante el almacenamiento.
MX2015007640A 2012-12-19 2013-12-17 Comprimidos que tienen aceptacion mejorada y buena stabilidad durante el almacenamiento. MX375182B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12198101 2012-12-19
PCT/EP2013/076878 WO2014095845A1 (de) 2012-12-19 2013-12-17 Tabletten mit verbesserter akzeptanz und guter lagerstabilität

Publications (2)

Publication Number Publication Date
MX2015007640A MX2015007640A (es) 2015-09-23
MX375182B true MX375182B (es) 2025-03-06

Family

ID=47458712

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007640A MX375182B (es) 2012-12-19 2013-12-17 Comprimidos que tienen aceptacion mejorada y buena stabilidad durante el almacenamiento.

Country Status (24)

Country Link
US (2) US10543170B2 (es)
EP (1) EP2934490B1 (es)
JP (1) JP6393274B2 (es)
KR (1) KR102253847B1 (es)
CN (1) CN105025885B (es)
AU (1) AU2013361760B2 (es)
CA (1) CA2895254C (es)
CL (1) CL2015001685A1 (es)
CR (1) CR20150321A (es)
DO (2) DOP2015000150A (es)
EC (1) ECSP15026203A (es)
ES (1) ES2848394T3 (es)
HK (1) HK1216856A1 (es)
IL (1) IL239297B (es)
MX (1) MX375182B (es)
MY (1) MY175703A (es)
NZ (1) NZ708741A (es)
PH (1) PH12015501390A1 (es)
PT (1) PT2934490T (es)
RU (1) RU2693005C2 (es)
SV (1) SV2015004997A (es)
UA (1) UA118748C2 (es)
WO (1) WO2014095845A1 (es)
ZA (1) ZA201505170B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014095845A1 (de) * 2012-12-19 2014-06-26 Bayer Animal Health Gmbh Tabletten mit verbesserter akzeptanz und guter lagerstabilität
CN106580896A (zh) * 2016-12-07 2017-04-26 成都乾坤动物药业股份有限公司 一种非班太尔分散片及其制备方法
EP3551173A1 (en) * 2016-12-09 2019-10-16 Bayer Animal Health GmbH Pharmaceutical preparation and method for its manufacture
RS66315B1 (sr) * 2018-09-05 2025-01-31 Zoetis Services Llc Palatabilne antiparazitne formulacije
KR20230061465A (ko) 2020-09-04 2023-05-08 엘랑코 유에스 인코포레이티드 기호성 제형

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746986A (en) 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4472405A (en) 1982-11-12 1984-09-18 Riker Laboratories, Inc. Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives
US4730000A (en) 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
AT392789B (de) 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
IN166416B (es) 1985-09-18 1990-05-05 Pfizer
DE3705227A1 (de) 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
FR2715803B3 (fr) 1994-02-04 1996-05-10 Attali Jean Claude Leurre et procédé facilitant la prise de médicaments par certains animaux et en particulier par les chiens.
DE670160T1 (de) 1994-03-01 1996-03-14 Gergely, Gerhard, Dr., Wien Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung.
DE19520275A1 (de) 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
US20040180034A1 (en) 2003-03-10 2004-09-16 Lyn Hughes Anthelmintic resinates and a method for their preparation
DE10328666A1 (de) 2003-06-26 2005-01-13 Bayer Healthcare Ag Tabletten enthaltend Geschmacks-und/oder Aromastoffe
AR045142A1 (es) 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
GB2407498B (en) 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US7348027B2 (en) 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
JP2007269716A (ja) * 2006-03-31 2007-10-18 Sato Pharmaceutical Co Ltd 塩酸セチリジン含有粒子
DE102008022520A1 (de) 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
JP5296456B2 (ja) * 2008-08-26 2013-09-25 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
WO2010132286A1 (en) 2009-05-12 2010-11-18 Wyeth Llc Orally administered tablet formulation of an antianxiolytic compound
GB2475701B (en) * 2009-11-26 2011-10-19 Michael Hilary Burke A process for the preparation of an orally administered anthelmintic unit dose tablet
WO2012049156A1 (en) 2010-10-12 2012-04-19 Bayer Animal Health Gmbh Non-starch based soft chewables
CN104168900A (zh) * 2012-02-06 2014-11-26 梅里亚有限公司 包含全身性地起作用的活性剂的杀寄生虫口服兽用组合物、方法及其用途
WO2014095845A1 (de) * 2012-12-19 2014-06-26 Bayer Animal Health Gmbh Tabletten mit verbesserter akzeptanz und guter lagerstabilität
GB201413832D0 (en) * 2014-08-05 2014-09-17 Tate & Lyle Ingredients Starch compositions useful for thickening aqueous liquids

Also Published As

Publication number Publication date
CA2895254C (en) 2021-01-26
PT2934490T (pt) 2020-12-15
CL2015001685A1 (es) 2015-10-23
ZA201505170B (en) 2025-02-26
NZ708741A (en) 2019-11-29
DOP2020000031A (es) 2020-02-28
JP2016503767A (ja) 2016-02-08
US20150342889A1 (en) 2015-12-03
EP2934490B1 (de) 2020-08-12
CN105025885A (zh) 2015-11-04
CN105025885B (zh) 2022-04-08
AU2013361760A1 (en) 2015-07-09
WO2014095845A1 (de) 2014-06-26
AU2013361760B2 (en) 2018-07-05
KR20150094643A (ko) 2015-08-19
PH12015501390A1 (en) 2015-09-02
IL239297A0 (en) 2015-07-30
ES2848394T3 (es) 2021-08-09
RU2015129310A (ru) 2017-01-24
CA2895254A1 (en) 2014-06-26
KR102253847B1 (ko) 2021-05-21
ECSP15026203A (es) 2016-01-29
MY175703A (en) 2020-07-06
US11147764B2 (en) 2021-10-19
CR20150321A (es) 2015-07-29
RU2693005C2 (ru) 2019-07-01
MX2015007640A (es) 2015-09-23
US10543170B2 (en) 2020-01-28
JP6393274B2 (ja) 2018-09-19
IL239297B (en) 2021-10-31
DOP2015000150A (es) 2015-07-15
HK1216856A1 (zh) 2016-12-09
SV2015004997A (es) 2017-05-12
UA118748C2 (uk) 2019-03-11
US20200113823A1 (en) 2020-04-16
EP2934490A1 (de) 2015-10-28

Similar Documents

Publication Publication Date Title
IL233713A0 (en) A hotspot for a social network
EP2962037A4 (en) BIOMASS PROPELLED HARVESTING EQUIPMENT WITH MOBILE PLATFORM
AU350872S (en) Storage battery
GB2506864B8 (en) Fuel briquette
SG10201609434XA (en) Microbial fuel cell
IL221664A0 (en) Bipolar battery
AU349741S (en) Storage battery
EP2943893A4 (en) PROVISION OF ORGANIZED CONTENT
ZA201505170B (en) Tablets with improved acceptance and good storage stability
GB201306326D0 (en) Fuel cells
EP2904577A4 (en) CONTENT ANALYSIS
EP2835852A4 (en) FUEL CELL
PL2617086T3 (pl) Akumulator, skrzynka akumulatora i sposób wytwarzania akumulatora
EP2964746A4 (en) FERMENTATION MONITORING DEVICE FOR FUEL CELL
EP2882020A4 (en) FUEL CELL
EP2939294A4 (en) DRUMS
IL227587A0 (en) An active compound for the spectral radiating trap when burning in the fire of the active compound, containing an additive
GB2500031B (en) Fuel cells
GB201307880D0 (en) Fuel cells
GB201502452D0 (en) Storage
GB201317614D0 (en) Fuel cell
GB201518180D0 (en) Fuel cell
EP2808929A4 (en) FUEL CELL
EP2804245A4 (en) FUEL CELL
Karlsson Fast etableringsställe: Ett enhetligt begrepp i mervärdesskattesystemet?

Legal Events

Date Code Title Description
FG Grant or registration